Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-25-001452
Filing Date
2025-04-02
Accepted
2025-04-02 16:12:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4076
  Complete submission text file 0000929638-25-001452.txt   5974
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Subject) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-53543 | Film No.: 25804600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814 (877) 843-3831
AdvisorShares Trust (Filed by) CIK: 0001408970 (see all company filings)

EIN.: 260636087 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A